Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
Carlos Doti, VP US Medical Affairs Oncology at AstraZeneca, shared on LinkedIn:
”As I reflect on another ASH, I’m reminded why this meeting is such a powerful close to the year – where science, collaboration and patient experiences come together to shape the future of hematology.
This year, I participated in two meaningful AstraZeneca events:
Moderating our annual Patient Advocacy Exchange panel with advocacy leaders focused on shared decision-making and patient navigation, discussing how to break down barriers and promote equitable access to care.
Hosting our first-ever AZHemeTalks – a live, pop-up series – at our booth, where I spoke with a clinical trial patient and her doctor about how treatment choices impact daily life.
The video here shows how we brought this activation to life through 4 expert panels focused on the treatment landscape in leukemia, lymphomas and multiple myeloma.”
Stay updated with Hemostasis Today.
-
Oct 5, 2026, 22:55Steve Humphreys: A Big Thank You to BSHT for Providing Me With a Recent Skills Exchange Award
-
Oct 5, 2026, 22:52William McKeown: Great to Be in Istanbul for the Opening of the EHC 2026
-
Oct 5, 2026, 22:48Laura Quintas Lorenzo: A New Approach to Healthcare for von Willebrand Disease at EHC 2026
-
Oct 5, 2026, 22:46Anas Zayad: Pleased to Share Our New Review on Thrombosis in SCD and Beta Thalassemia
-
Oct 5, 2026, 22:44Cihan Ay: Honouring Eric Kandel and Eugene Braunwald at the Medical University of Vienna
-
Oct 5, 2026, 22:42Heather L. Gornik: Testing for Aortic and Arterial Thrombosis at VSS 2026
-
Oct 5, 2026, 22:34Hasan Abbas Zaheer: Honoured to Have Co-Authored One of the Four Reviews in The Lancet Thalassemia Series
-
Oct 5, 2026, 22:34Kamyar Shameli: Understanding the Coagulation Cascade – How Anticoagulants Prevent Blood Clots
-
Oct 5, 2026, 22:31Risika Samanta: Pediatric ITP in a 12-year-old – An Atypical Presentation without a Viral Prodrome